Patents by Inventor Jessica Sun

Jessica Sun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Flexible sharing in shared computer environments
    Patent number: 11972299
    Abstract: A sharable resource of a first user's environment is identified. The sharable resource is configured as sharable in a shared computer environment. A matching resource that is sufficiently similar to the sharable resource is located. The matching resource is used by pre-existing users of the shared computer environment. Agreement from the pre-existing users for the first user to access the matching resource is obtained. The first user is then provided access to the matching resource.
    Type: Grant
    Filed: June 22, 2021
    Date of Patent: April 30, 2024
    Assignee: International Business Machines Corporation
    Inventors: Jingdong Sun, Roger Mittelstadt, Rafal Konik, Jessica R. Eidem
  • Liquid Composition With Encapsulated Fragrance And Alcohol Ethoxylate Suitable For Use With Unit Dose Packages
    Publication number: 20240101930
    Abstract: A liquid fabric treatment composition suitable for encapsulation in a unit dose pack contains from about 3% by weight to about 8% by weight of an alcohol ethoxylate, from about 10% by weight to about 70% by weight of an encapsulated fragrance slurry; from about 0.5% by weight to about 5% by weight of a rheology modifier; from about 0.1% by weight to about 3% by weight of a pH adjusting agent; and from about to about 5% by weight to about 60% by weight of non-aqueous solvent. The liquid composition is stable at elevated temperatures and has a lower yield stress and a lower storage modulus than a composition having no alcohol ethoxylate.
    Type: Application
    Filed: September 9, 2022
    Publication date: March 28, 2024
    Inventors: Jessica Eileen McKeon, Wei Sun, Brian Alan Warren, Rebekah Cathleen Seabury
  • Methods for the treatment of autism spectrum disorders
    Patent number: 11813294
    Abstract: The present disclosure provides methods for the treatment of autism spectrum disorders. More particularly, the present disclosure relates to methods of using cord blood for the treatment of autism spectrum disorders.
    Type: Grant
    Filed: February 8, 2021
    Date of Patent: November 14, 2023
    Assignee: DUKE UNIVERSITY
    Inventors: Joanne Kurtzberg, Geraldine Dawson, Jesse Troy, Jessica Sun
  • METHODS OF TREATING CEREBRAL PALSY AND HYPOXIC-ISCHEMIC ENCEPHALOPATHY USING HUMAN UMBILICAL CORD TISSUE-DERIVED MESENCHYMAL STROMAL CELLS
    Publication number: 20210361716
    Abstract: The present invention relates to methods of treating cerebral palsy and hypoxic-ischemic encephalopathy using cord blood tissue-derived mesenchymal stromal cells.
    Type: Application
    Filed: April 4, 2019
    Publication date: November 25, 2021
    Applicant: DUKE UNIVERSITY
    Inventors: Joanne Kurtzberg, Jessica Sun, Allen Song, Charles Michael Cotten
  • Methods for the Treatment of Autism Spectrum Disorders
    Publication number: 20210244772
    Abstract: The present disclosure provides methods for the treatment of autism spectrum disorders. More particularly, the present disclosure relates to methods of using cord blood for the treatment of autism spectrum disorders.
    Type: Application
    Filed: February 8, 2021
    Publication date: August 12, 2021
    Applicant: DUKE UNIVERSITY
    Inventors: Joanne Kurtzberg, Geraldine Dawson, Jesse Troy, Jessica Sun
  • METHODS OF TREATING AUTISM SPECTRUM DISORDERS USING HUMAN UMBILICAL CORD TISSUE-DERIVED MESENCHYMAL STROMAL CELLS
    Publication number: 20210128631
    Abstract: The present disclosure provides methods of treating Autism Spectrum Disorder. More particularly, the present disclosure relates to methods of using cord blood tissue-derived mesenchymal stromal cells to treat Autism Spectrum Disorder.
    Type: Application
    Filed: April 4, 2019
    Publication date: May 6, 2021
    Applicant: DUKE UNIVERSITY
    Inventors: Joanne Kurtzberg, Geraldine Dawson, Jessica Sun
  • Methods for the treatment of autism spectrum disorders
    Patent number: 10912801
    Abstract: The present disclosure provides methods for the treatment of autism spectrum disorders. More particularly, the present disclosure relates to methods of using cord blood for the treatment of autism spectrum disorders.
    Type: Grant
    Filed: March 13, 2018
    Date of Patent: February 9, 2021
    Assignee: DUKE UNIVERSITY
    Inventors: Joanne Kurtzberg, Geraldine Dawson, Jesse Troy, Jessica Sun
  • Methods for the Treatment of Autism Spectrum Disorders
    Publication number: 20200069741
    Abstract: The present disclosure provides methods for the treatment of autism spectrum disorders. More particularly, the present disclosure relates to methods of using cord blood for the treatment of autism spectrum disorders.
    Type: Application
    Filed: March 13, 2018
    Publication date: March 5, 2020
    Inventors: Joanne Kurtzberg, Geraldine Dawson, Jesse Troy, Jessica Sun
  • Methods of Treating Cerebral Palsy Using High Dose Allogeneic Umbilical Cord Blood
    Publication number: 20200016213
    Abstract: The present disclosure relates to methods of treating cerebral palsy. More particularly, the present disclosure relates to methods of using a high dose of allogeneic umbilical cord blood to treat cerebral palsy.
    Type: Application
    Filed: July 12, 2019
    Publication date: January 16, 2020
    Inventors: Joanne Kurtzberg, Jessica Sun
  • Methods of Treating Brain Injury Using Cord Blood or a Component Thereof
    Publication number: 20190350985
    Abstract: The present disclosure relates to methods of treating cerebral palsy and hypoxic-ischemic brain injury. More particularly, the present disclosure relates to methods of using cord blood or components thereof to treat cerebral palsy and hypoxic-ischemic brain injury. The present disclosure also relates to methods of assessing neuroprotective activity of a neuroprotective agent.
    Type: Application
    Filed: January 12, 2018
    Publication date: November 21, 2019
    Inventors: Joanne Kurtzberg, Jessica Sun, Ana Valverde Vidal, Jesse Troy, C. Michael Cotten, Andrew Balber, Daniel Laskowitz, Arjun Saha
  • Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancer
    Publication number: 20190060275
    Abstract: Administration of a hypoxia activated prodrug in combination with an antiangiogenic agent is useful for treating cancer.
    Type: Application
    Filed: August 17, 2018
    Publication date: February 28, 2019
    Applicant: Molecular Templates, Inc.
    Inventors: Charles Hart, John Curd, Stewart Kroll, Jessica Sun
  • PREDICTIVE AND RESPONSE BIOMARKER FOR TH-302 ANTI-CANCER THERAPY
    Publication number: 20160296538
    Abstract: Cancer patients likely to respond to HAP treatment exhibit tumor tissues with high levels of hypoxia, which can be measured using PET imaging with [18F]-HX4.
    Type: Application
    Filed: April 9, 2014
    Publication date: October 13, 2016
    Applicant: THRESHOLD PHARMACEUTICALS, INC.
    Inventors: Charles Hart, Harold E. Selick, Jessica Sun
  • Administration of hypoxia activated prodrugs in combination with Chk1 inhibitors for treating cancer
    Patent number: 9254299
    Abstract: Cancer can be treated by administration of TH-302 in combination with a Chk1 inhibitor.
    Type: Grant
    Filed: December 20, 2012
    Date of Patent: February 9, 2016
    Assignee: Threshold Pharmaceuticals, Inc.
    Inventors: Charles Hart, Fanying Meng, Jessica Sun
  • ADMINISTRATION OF HYPOXIA ACTIVATED PRODRUGS IN COMBINATION WITH CHK1 INHIBITORS FOR TREATING CANCER
    Publication number: 20150005263
    Abstract: Cancer can be treated by administration of TH-302 in combination with a Chk1 inhibitor.
    Type: Application
    Filed: December 20, 2012
    Publication date: January 1, 2015
    Inventors: Charles Hart, Fanying Meng, Jessica Sun
  • HYPOXIA ACTIVATED PRODRUGS AND MTOR INHIBITORS FOR TREATING CANCER
    Publication number: 20150005262
    Abstract: Cancer is treated by administration of a hypoxia activated prodrug in combination with an mTOR inhibitor.
    Type: Application
    Filed: December 20, 2012
    Publication date: January 1, 2015
    Inventors: Charles Hart, Jessica Sun, Fanying Meng